1,846 reports of this reaction
7.5% of all VALGANCICLOVIR HYDROCHLORIDE POWDER, reports
#1 most reported adverse reaction
OFF LABEL USE is the #1 most commonly reported adverse reaction for VALGANCICLOVIR HYDROCHLORIDE POWDER,, manufactured by Ajanta Pharma USA Inc.. There are 1,846 FDA adverse event reports linking VALGANCICLOVIR HYDROCHLORIDE POWDER, to OFF LABEL USE. This represents approximately 7.5% of all 24,571 adverse event reports for this drug.
Patients taking VALGANCICLOVIR HYDROCHLORIDE POWDER, who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OFF LABEL USE is moderately reported among VALGANCICLOVIR HYDROCHLORIDE POWDER, users, representing a notable but not dominant share of adverse events.
In addition to off label use, the following adverse reactions have been reported for VALGANCICLOVIR HYDROCHLORIDE POWDER,:
The following drugs have also been linked to off label use in FDA adverse event reports:
OFF LABEL USE has been reported as an adverse event in 1,846 FDA reports for VALGANCICLOVIR HYDROCHLORIDE POWDER,. This does not prove causation, but indicates an association observed in post-market surveillance data.
OFF LABEL USE accounts for approximately 7.5% of all adverse event reports for VALGANCICLOVIR HYDROCHLORIDE POWDER,, making it one of the most commonly reported side effect.
If you experience off label use while taking VALGANCICLOVIR HYDROCHLORIDE POWDER,, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.